IP Library Granted Patent US 10,577,304
Granted Patent B2
US 10,577,304 · App. 16/192,387 · Granted Mar 3, 2020

Site-specific isotopic labeling of 1,4-diene systems

Inventors: Dragoslav Vidovic (Belgrade, RS); Mikhail Sergeevich Shchepinov (Kingston upon Thames, GB)
Assignee: Retrotope, Inc.
C07C67/30C07B59/001C07C5/00C07C11/12C07C29/00C07C51/347C07C407/00C07B2200/05C07C2523/46C07C2531/22C07C2531/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,577,304
App. No.
16/192,387
Granted
Mar 3, 2020
Kind
B2
Abstract

Methods for preparing isotopically modified 1,4-diene systems from non-isotopically modified 1,4-dienes involve selective oxidation of one or more bis-allylic position(s), or the preparation of isotopically modified 1,4-diene systems via trapping pi-allylic complexes with a source of deuterium or tritium. Such methods are useful for preparing isotopically modified polyunsaturated lipid including polyunsaturated fatty acids and polyunsaturated fatty acid derivatives.

Claims (17)

1. A compound of the formula:

wherein: R 5 is an unsubstituted C 1 -C 5 alkyl group; and each Y is independently deuterium or tritium.

2. The compound of claim 1 , wherein R 5 is an unsubstituted ethyl.

3. The compound of claim 1 , wherein each Y is deuterium.

4. The compound of claim 1 , wherein R 5 is an unsubstituted ethyl; and each Y is deuterium.

5. The compound of claim 1 , wherein the compound has an isotopic load that is in a range of from about 25% to about 30%.

6. A composition comprising

and one or both of eicosapentaenoic acid and docosahexaenoic acid, wherein:

R 5 is an unsubstituted C 1 -C 5 alkyl group; and

each Y is independently deuterium or tritium.

7. The composition of claim 6 , wherein R 5 is an unsubstituted ethyl.

8. The composition of claim 6 , wherein each Y is deuterium.

9. The composition of claim 6 , wherein R 5 is an unsubstituted ethyl; and each Y is deuterium.

10. The composition of claim 6 , wherein the isotopic loads of the compounds are independently in a range of from about 25% to about 30%.

11. The composition of claim 6 , wherein the composition has an isotopic purity in a range of about 5% to about 99%.

12. The composition of claim 6 , wherein the composition has an isotopic purity in a range of about 5% to about 50%.

13. The composition of claim 6 , wherein the composition has an isotopic purity in a range of about 5% to about 25%.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 9, 2022
From: RTMFP ENTERPRISES INC.
To: RETROTOPE, INC.
Reel/Frame 061403/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2022
From: RETROTOPE, INC.
To: RTMFP ENTERPRISES INC.
Reel/Frame 061403/0835 →
CHANGE OF NAME Recorded Sep 9, 2022
From: RTMFP ENTERPRISES INC.
To: BIOJIVA LLC
Reel/Frame 061405/0819 →
SECURITY INTEREST Recorded Mar 30, 2022
From: RETROTOPE, INC.
To: RTMFP ENTERPRISES, INC.
Reel/Frame 059442/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2019
From: VIDOVIC, DRAGOSLAV; SHCHEPINOV, MIKHAIL SERGEEVICH
To: RETROTOPE, INC.
Reel/Frame 051110/0921 →
Continuity (3)
Continuation 15778182
Provisional Application 62258993 · Nov 23, 2015
Related Publication 20190084913A1 · Mar 21, 2019
Cited By (1)
US 12,697,319